Hallmarks in the Therapeutic Approach of Aortic Aneurysms: The Main Contributors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|28|3996-3999

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.28, 2015-08, pp. : 3996-3999

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Role of Endothelial Dysfunction in Aortic Aneurysms

By  

Current Pharmaceutical Design, Vol. 21, Iss. 28, 2015-08 ,pp. : 4016-4034

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Target Hsp90 and Cancer Hallmarks

By  

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 347-365

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of Macrolide Treatment of Atherosclerosis and Abdominal Aortic Aneurysms

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 1, 2003-03 ,pp. : 55-63

Bentham Science Publishers

Access to resources Recommend Favorite

Experimental Models of Abdominal Aortic Aneurysms: An Overview

By  

Current Pharmaceutical Design, Vol. 14, Iss. 4, 2008-02 ,pp. : 325-337

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin II and Abdominal Aortic Aneurysms: An update

By  

Current Pharmaceutical Design, Vol. 21, Iss. 28, 2015-08 ,pp. : 4035-4048

Bentham Science Publishers

Access to resources Recommend Favorite